INTRODUCTION
10) in response to a specific antigen. There may be a good reason for this persisting dislike of a term that The Th1/Th2 dichotomy (1) is shorthand for the ob-seems to have a molecular basis: cytokines are pleiotroservation that the antigen-specific activation of CD4 pic and a particular cytokine such as TGFb may be T cells can lead to two seemingly opposed biological suppressive for one target (Th1 T cells, for example) outcomes: the secretion of ''proinflammatory'' cytokines and, at the same time, stimulatory for a different target (the Th1 phenotype) or the secretion of ''anti-inflam-(fibroblasts, for example). Th1/Th2 terminology refers matory'' cytokines (the Th2 phenotype). The Th1/Th2 directly to packages of cytokines and only indirectly to dichotomy is only two of several response phenotypes cellular behavior. Th2 and Th1 T cells may, without that can be elicited by a single antigen. For example, offending a single immunologist, suppress the activithe CD8 T-cell response can be expressed as cytotoxic-ties of the other T-cell type while enhancing the activiity or suppression, and a single antibody specificity, ties of their own camp. Nevertheless, the Th1/Th2 diexpressed by the antibody's variable moiety, can mobi-chotomy carries the hazard of its own phenomenologilize a variety of biological effects, depending on the cal oversimplification, an issue to which I shall return class and isotype of the constant region of the antibody. at the end. Thus, when mounting a response, the immune system has to weigh options. The Th1/Th2 cytokine option is TYPE I DIABETES currently popular because this dichotomy can influence, for better or worse, the fate of the individual responding to an infectious agent, to tumor cells, or to a Type I diabetes, or insulin-dependent diabetes mellitus (IDDM), designates the diabetes that results from self-antigen in an autoimmune situation. Historically, the phenomenon we now call Th1/Th2 was described autoimmune destruction of the insulin-producing b cells of the pancreatic islets (4). The disease used to be long ago as ''immune deviation,'' denoting the capacity of an immune response to be expressed primarily either called juvenile diabetes because it appeared to be limited to young persons, in contrast to adult-onset nonby antibody production or by ''cell-mediated'' immunity (2). Early evidence suggested that different populations insulin-dependent diabetes mellitus. However, it is now clear that the incidence of type I diabetes is inof T cells provided help for antibody production and mediated cellular reactions (3). The renaissance of in-creasing and the disease can develop in adults into the fifth and sixth decades of life. Although the developterest in T-cell classes springs from the discovery of cytokines and their classification into Th1 and Th2 ment of IDDM requires a susceptible genetic background with a strong HLA effect (5), the autoimmune groupings (1). Such is the nature of the scientific enterprise; a phenomenon, such as immune deviation, will process would seem to require environmental triggering. The increasing incidence of IDDM in Northern lose the attention of the research community unless study of the phenomenon leads to a molecular mecha-industrialized societies is compatible with environmental toxins as triggers. nism that explains it. The decline of interest in immune deviation could only be reversed by the discovery of It has been difficult to study the natural history of IDDM autoimmunity in people because the autoim-a Th1-like phenotype to a Th2-like phenotype (19). The spleen cells of p277-treated mice responded to p277 (or mune process proceeds without symptoms or signs until the loss of b cells nears completion and the lack of to hsp60) by secreting the Th2 cytokines IL-4 and IL-10; sham-treated mice continued to manifest spontaneinsulin surfaces more or less abruptly as an endocrine disease. The autoimmune process by then is winding ous T-cell reactivity to p277 expressed by the secretion the Th1 cytokines IFN-g and IL-2 (19). The shift in down and it is difficult to sort out primary and secondary processes. Particularly nagging has been the sur-cytokine production was accompanied by the appearance of antibodies to p277 of the IgG1 and IgG2b isofeit of target autoantigens to which IDDM patients manifest T-and B-cell autoimmunity (6). The NOD types (19). IgG1 depends on IL-4 (20) and IgG2b on TGFb (21) . Thus, the induction of antibodies to p277 mouse, which features an MHC susceptibility gene very similar to the human HLA-DQ 0302 molecule (7) was also compatible with a ''deviation'' of the p277 response. The Th2 activity induced by p277 peptide treatand develops IDDM spontaneously (8), also manifests autoimmune responses to more than one functionally ment was transient and IL-4 and IL-10 secretion in response to p277 waned 1-2 months after treatment important target antigen (6). Thus, there may be no single primary autoimmune target in IDDM, but the (19). However, no Th1 reactivity to p277 recurred and the diabetic process did not return. Thus, p277 treatdisease may involve a collective of autoreactivities (9). ment seemed to trigger a resetting of the cytokine profile of the autoimmune reaction following a transient
THE hsp60 CONNECTION
wave of Th2 reactivity that ''suppressed'' the pathoMy colleagues and I discovered, quite unexpectedly, genic Th1 reactivity. that NOD mice, early in the process of b-cell destruction, spontaneously developed autoantibodies and au-
SPREADING REGULATION
toimmune T cells reactive to the 60-kDa heat shock protein (hsp60) of the mouse (10, 11), cross-reactive How can a shift in the immune response phenotype to with the hsp65 molecule of Mycobacteria (12). Cloning a single peptide arrest a pathogenic process involving and sequencing of the mouse hsp60 molecule led to autoreactivities to a collective of self-antigens? The the identification of a 24-amino-acid segment of the Th1/Th2 modulation of NOD diabetes shows both spemolecule, positions 437-460, designated peptide p277 cific and nonspecific aspects that sharpen this question. (10, 11). This peptide was recognized by a pathogenic Specificity was evidenced by the fact that the same clone of NOD T cells, and immunization to the p277 population of spleen cells that showed a Th1 to Th2 peptide conjugated to an immunogenic carrier molecule shift in anti-p277 reactivity, persisted in showing a could induce transient hyperglycemia and insulitis spontaneous Th1 (IL-2, IFN-g) response to a bacterial even in mouse strains not otherwise prone to develop hsp60 peptide not cross-reactive with self-hsp60 (19). diabetes (13). The triggering of autoimmune diabetes Thus, it was only the anti-self-reactivity that shifted in mice of the C57Bl/KsJ strain by an ultra-low dose its phenotype. Spreading of regulation to other IDDMof the toxin streptozotocine was accompanied by the associated antigens was seen, however, in the p277-appearance of antibodies to hsp60 and T cells reactive treated mice. Th1-type T cell responses and Th1-type to hsp60 and its p277 peptide (14). The p277 peptide antibodies to other antigens such as insulin and glufeatures a motif that allows binding to the MHC class tamic acid decarboxylase were found to be down-regu-II molecule IA g7 of the NOD mouse (7) and to the sus-lated (19). Thus, inhibiting the Th1 response to p277 ceptible human HLA-DQ 0302 molecules (15). Indeed, was associated with suppressed Th1 responses to other newly diagnosed human IDDM patients also show T-antigens in the IDDM collective, albeit not to foreign cell responses to p277 (in preparation). Thus, T-cell antigens. reactivity to p277 is associated with autoimmune diaSpreading down-regulation was most impressive in betes in mice and men.
the islet infiltrating T cell population. We developed an ELISPOT system (22) for enumerating the actual numbers of islet T cells producing various cytokines
PEPTIDE INDUCTION OF A Th1 r Th2 SHIFT
upon activation with T-cell mitogenic anti-CD3 antibodies (23). Using this technique, we could document Most interesting was our finding that the destruction of b cells could be arrested, even when very far ad-the numbers of all islet T cells capable of secreting particular cytokines before and after treatment. The vanced, by a single subcutaneous administration of peptide p277 (100 mg) emulsified in oil (10, 11, 16, 17). progression of b-cell destruction was clearly associated with the spontaneous accumulation of IFN-g-secreting Treatment of the IDDM triggered by streptozotocine required a second injection of p277 (18).
T cells in the islets. Following p277 peptide treatment, there was an abrupt fall in the numbers of IFN-g proStudy of the immunology of p277 treatment was compatible with a shift in anti-p277 T-cell reactivity from ducers in the islets, followed by a general fall in islet 1. Mosmann, T. R., and Coffman, R. L., TH1 and TH2 cells: Differno T cells producing IL-4 or IL-10 in the islets associ- of IFN-g producers in response to p277, without a shift 7. Reizis, B., Eisenstein, M., Bockova, J., Könen-Waisman, S., Mor, to IL-4 producers (in preparation). ily taught than are complex ideas. The simple, in addi- 
